Cargando…
Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy
BACKGROUND: Little is known about the effects of human fetal exposure when a new drug is authorized unless it was specifically developed for use in pregnancy. Since many factors may contribute to adverse fetal effects, having comprehensive information about in utero exposures will enhance our abilit...
Autores principales: | Dreyer, Nancy A, Blackburn, Stella CF, Mt-Isa, Shahrul, Richardson, Jonathan L, Thomas, Simon, Laursen, Maja, Zetstra-van der Woude, Priscilla, Jamry-Dziurla, Anna, Hliva, Valerie, Bourke, Alison, de Jong-van den Berg, Lolkje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869223/ https://www.ncbi.nlm.nih.gov/pubmed/27227140 http://dx.doi.org/10.2196/publichealth.4939 |
Ejemplares similares
-
An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy
por: Richardson, Jonathan Luke, et al.
Publicado: (2016) -
Balancing the Interests of Patient Data Protection and Medication Safety Monitoring in a Public-Private Partnership
por: Dreyer, Nancy A, et al.
Publicado: (2015) -
Patient-reporting of side effects may provide an important source of information in clinical practice
por: Foster, Juliet M., et al.
Publicado: (2007) -
The Voice of Parents of Children With a Congenital Anomaly – A EUROlinkCAT Study
por: Holm, Kristina Garne, et al.
Publicado: (2021) -
Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008)